Contact this trialFirst, we need to learn more about you.
Small Molecule
Adagrasib + Durvalumab for KRAS-Mutated Lung and Gastrointestinal Cancer
Recruiting1 awardPhase 1
Houston, Texas
This trial is studying the best dose of two drugs for people with KRAS-mutated cancer.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.